advert
advert
Angel News

Back to Homepage

7th December 2021 - 0 comments

Vinehealth raises $5.5m led by Talis Capital

Vinehealth has raised $5.5m in seed funding. The round was led by Talis Capital, with participation from previous investors Playfair Capital and Ascension. 

7th December 2021 - 0 comments

Oxford Capital leads $2.5m seed round in National MRI Scan

As the UK experiences record waiting times for diagnostic imaging, Digital Health startup, National MRI has raised $2.5m seed led by Oxford Capital, YZR, Founders Factory, KM Capital and well-known industry angels Tom Blomfield, Evelyne Bourke (ex-BUPA CEO) and Harry Hurst (PIPE CEO).

6th December 2021 - 0 comments

Neuro-tech firm Neurovalens secures funds from Invest Northern Ireland

Neurovalens, a global leader in non-invasive neuro-technology, has secured new funding towards the development of mental health treatments that target Generalised Anxiety Disorder, Insomnia and Post Traumatic Stress Disorder (PTSD).

30th November 2021 - 0 comments

British Patient Capital backs Quell Therapeutics’ $156m funding

British Patient Capital has participated in Quell Therapeutics’ $156m Series B funding round. The deal is the first life sciences  investment from Future Fund: Breakthrough, a £375m programme where British Patient Capital co-invests with private sector investors in innovative R&D-intensive UK companies.

22nd November 2021 - 0 comments

Pioneering medtech firm Glyconics secures £1.5m in oversubscribed raise

Award-winning medtech firm, Glyconics© has secured £1.5million in an Enterprise Investment Scheme (EIS) funding round ahead of a series A round next year. The innovative diagnostics startup, with offices in Cambridge, Norwich and Basingstoke, raised well over the intended £850k in a raise led by investment platform Wealth Club and existing investors, Deepbridge Capital and Boundary Capital. Demand from Wealth Club private investors and angel investors pushed the total amount further to £1.5 million.

19th November 2021 - 0 comments

Charco raises $10m for wearable device to ease Parkinson’s symptoms

Charco Neurotech, a medical technology company that develops solutions for people with Parkinson’s, has raised $10m seed investment round, co-led by technology investors Amadeus Capital Partners and Parkwalk Advisors, and joined by University of Tokyo Edge Capital Partners (UTEC), MINT Venture Partners, and existing investors, including Crista Galli Ventures. The financing is the largest European seed round in 2021 and the sixth largest globally for healthtech devices, according to Pitchbook.

Charco is a multi-award winning, Imperial College spinout. Its first therapeutic device, CUE1, provides life-changing neuromodulation therapy.

16th November 2021 - 0 comments

Contract research firm Gentronix set to expand following £700k investment

Gentronix, the UK-based contract research organisation (CRO) that is a leader in the field of genetic toxicology, has raised £700,000 in a funding round led by existing investor Mercia to support its continued growth.

12th November 2021 - 0 comments

Kernel Capital portfolio company B-Secur raises £8.8m

Kernel Capital portfolio company B-Secur Ltd, a Belfast-based health tech company, has completed a total raise of £8.8 million (USD $12 million) of investment in 2021, with the latest round led by US-based First Capital Ventures and The Bank of Ireland Kernel Capital Growth Fund NI increasing its investment level to £2.2M with other existing investors also participating.

8th November 2021 - 0 comments

UK healthtech firm Forth raises £1.6M for ground-breaking FemTech product

Chepstow based health tech firm Forth is set to capitalise on the growth in the female science and technology market as it has secured £1.6m funding to support the launch of its ground-breaking female health product. Leading the team at Forth is CEO and Co-Founder Sarah Bolt. She said: “Today, more and more people are realising that understanding and measuring your body’s biochemistry is key for a long and healthy life. For women in particular, gaining unique insight into how their hormone levels fluctuate throughout their unique cycle can give women the support they have been lacking and help to close the gender health gap”. 

4th November 2021 - 0 comments

BGF leads £13m investment in Closed Loop Medicine

Closed Loop Medicine, the global leader in the development of single prescription drug plus digital therapy (DTx) combination products to enable precision dosing, has closed a £13 million financing. 

4th November 2021 - 0 comments

Forward Partners VC Louise Rix joins Béa Fertility as Chief Medical Officer

Dr Louise Rix, a former VC at Forward Partners, is stepping into the start-up world and taking up a new role as Chief Medical Officer at femtech start-up Béa Fertility. 

4th November 2021 - 0 comments

Maven invests £3.25 million in healthcare analytics specialist RwHealth

Maven Capital Partners, one of the UKs most active investors in growing businesses,  has invested £3.25 million in London-based RwHealth 

PREVIOUSItems 192 of 573NEXT

Back to Homepage